Can You Take Metoprolol and Verapamil Together?

Metoprolol and verapamil should not be used together without close medical supervision because the combination carries a documented major interaction risk. Both medications slow heart rate and atrioventricular conduction in a way that adds together, increasing the risk of dangerously low heart rate (bradycardia). This is a serious interaction that requires explicit approval and monitoring from a physician or cardiologist.

What the Source Says

According to FDA-sourced drug labeling data, the interaction between metoprolol and verapamil is classified as major severity. The documented description states: Concomitant use increases risk of bradycardia. Both agents slow atrioventricular conduction and decrease heart rate. The mechanism of interaction is identified as additive negative chronotropic effects—meaning both drugs independently reduce heart rate, and when taken together, their effects combine and amplify.

This interaction record is sourced from NLP analysis of metoprolol prescribing information, last updated May 5, 2026. It reflects warnings and contraindications present in the FDA drug labeling for these medications.

How to Understand This

To understand what this interaction means, it helps to know what each drug does on its own.

Metoprolol is a beta-blocker—a class of medication that reduces the workload on the heart by slowing its rate and weakening the force of contractions. Beta-blockers are commonly prescribed for high blood pressure, angina, heart failure, and irregular heart rhythms. One of their intended effects is to lower heart rate; this is therapeutic when the rate is too high, but problematic if the rate drops too low.

Verapamil is a calcium channel blocker—a different drug class that works by relaxing blood vessels and slowing conduction of electrical signals through the heart. Verapamil is used for similar conditions: high blood pressure, angina, and certain arrhythmias. Like metoprolol, verapamil slows heart rate and weakens atrial contractions as part of its mechanism.

The problem when combined: When both drugs are present in the bloodstream at the same time, their heart-rate-lowering effects do not simply add in a straightforward way—they amplify each other. A patient taking an appropriate dose of metoprolol alone might maintain a safe heart rate. A patient taking an appropriate dose of verapamil alone might also maintain a safe heart rate. But together, even at standard doses, the heart rate can drop to dangerous levels. The source record identifies this additive effect as the documented mechanism: additive negative chronotropic effects. "Chronotropic" refers to the rate of the heartbeat; "negative" means slowing.

Additionally, both drugs slow conduction through the atrioventricular (AV) node, the electrical relay station in the heart that controls timing between the upper chambers (atria) and lower chambers (ventricles). Combined, they can delay or block this electrical signal, leading to heart rhythms that are too slow or irregular.

Who Should Pay Particular Attention

Anyone for whom one of these drugs has already been prescribed should be aware of this interaction. Patients who are older, have underlying heart disease, heart failure, or conduction disorders (such as first-degree AV block) may be at higher risk for serious consequences from an excessively slow heart rate. Similarly, patients who are taking other medications that slow heart rate or affect cardiac conduction should be especially alert.

However, the interaction is not an absolute contraindication. In some carefully selected patients—for example, those with certain types of arrhythmias that require simultaneous control of rate and rhythm—a cardiologist may choose to prescribe both drugs together while implementing careful monitoring. The key is that this decision must be made intentionally and supervised closely.

Hypothetical Scenario: Additive Heart-Rate Effects

Consider a hypothetical patient (not a real case) being treated for high blood pressure with metoprolol 50 mg twice daily. The patient's resting heart rate on this regimen is stable at 60 beats per minute. The patient then develops a different condition—for example, paroxysmal atrial fibrillation—and a new physician, unaware of the metoprolol, prescribes verapamil 120 mg daily to control the heart rate during episodes.

Within days, the patient notices fatigue, dizziness when standing, and shortness of breath. Upon checking the heart rate, it has dropped to 42 beats per minute. The pharmacy catch—or better, a communication between the two physicians—reveals the interaction. Because both drugs slow the heart independently and their effects have added together, the combined dose is producing bradycardia. The solution typically involves reducing or discontinuing one drug, adjusting doses, or switching to a different medication for one of the conditions—decisions that must be made by the prescribing team and the patient together.

Another Hypothetical: When Combination Therapy May Be Intentional

In another hypothetical scenario, a cardiologist sees a patient with heart failure and uncontrolled supraventricular tachycardia (fast heart rhythm originating above the ventricles). The cardiologist believes that the combination of metoprolol and verapamil—each at a carefully chosen lower dose—will be more effective at controlling the rhythm and improving heart function than either drug alone. In this case, the cardiologist may knowingly prescribe both drugs together, but only after discussing the risks, selecting doses that minimize bradycardia risk, and scheduling regular follow-up appointments to check the patient's heart rate via physical exam or telemetry. This illustrates that the interaction, though major, does not mean the drugs can never be used together—only that any combined use must be deliberate, informed, and monitored.

What to Discuss With a Pharmacist or Physician

If you are currently taking metoprolol and verapamil together, or if you have been prescribed one of these drugs and are aware you are also taking the other, here are questions and considerations to raise with your healthcare team:

• Is the combination intentional? Ask your pharmacist and physician whether both drugs have been prescribed knowingly and whether they are aware of each other's presence. Sometimes one is prescribed by a specialist and another by a primary care physician, and neither may be fully aware of the other.
• Why am I taking both? Understand the clinical reason. Is one being used to treat blood pressure, another for arrhythmia, and a third for angina? Or might a single alternative medication address your conditions? Your doctor may have good reasons, but asking clarifies your care.
• What is my target heart rate? Ask what resting heart rate your doctor considers acceptable and safe for you. This gives you a benchmark for monitoring at home if you have a blood pressure cuff with pulse display.
• How often should my heart rate and rhythm be checked? Ask whether you need follow-up EKGs, in-office vital signs, or home monitoring (such as a pulse oximeter). The source record indicates a major interaction, so surveillance is appropriate.
• What symptoms should prompt an urgent call or visit? Ask specifically about dizziness, severe fatigue, fainting, shortness of breath at rest, or very slow or irregular heartbeats. These may signal bradycardia or conduction problems.
• Are there alternative medications? If you are uncomfortable with the combination, ask whether substitutions are possible. Many conditions can be treated with alternative agents that do not interact.
• What if I miss a dose or accidentally double-dose? Understand the protocol. With this interaction, a missed or extra dose becomes more relevant.

Key Takeaways

• Metoprolol and verapamil together carry a documented major interaction because both slow heart rate and atrioventricular conduction; their effects are additive and can lead to dangerous bradycardia.
• The source mechanism is additive negative chronotropic effects—both drugs independently reduce heart rate, and combined they amplify this effect.
• This interaction does not automatically mean the drugs cannot be used together, but any combined use must be intentional, explicitly approved by a physician, and carefully monitored.
• Patients on both medications should know their target heart rate, understand warning symptoms, and have a plan for regular heart-rate checks.
• Always confirm with a pharmacist or physician whether both drugs have been prescribed knowingly and whether the combination is appropriate for your specific conditions.

Sources

• FDA Open Data Portal (Drug Labeling) — Source of metoprolol and verapamil prescribing information and interaction data.
• DailyMed (National Library of Medicine) — Full prescribing labels for metoprolol and verapamil, including warnings and contraindications.
• RxNorm (National Library of Medicine) — Standardized drug nomenclature and relationship data.
• PubMed (National Center for Biotechnology Information) — Peer-reviewed literature on cardiac drug interactions and bradycardia management.

If you are taking metoprolol, verapamil, or both, visit checkdruginteractions.com to check your full medication list for documented interactions. Then schedule a conversation with your pharmacist or physician to confirm that all your medications have been prescribed knowingly and are appropriate for your conditions. Never start, stop, skip, or change a dose of either medication without explicit guidance from your healthcare provider.